Oncodesign Services acquiert ZoBio
Oncodesign Services (ODS) annonce son expansion à l’international avec l’acquisition de ZoBio, un CRO néerlandais expert dans la découverte de médicaments à petites molécules basés sur la biophysique.
OPM annonce le lancement de la phase I de l’ODS-101
[fusion_builder_container hundred_percent="no" equal_height_columns="no" hide_on_mobile="small-visibility,medium-visibility,large-visibility" background_position="center center" background_repeat="no-repeat" fade="no" background_parallax="none" enable_mobile="no" parallax_speed="0.3" video_aspect_ratio="16:9" video_loop="yes" video_mute="yes" border_style="solid" padding_top="20px" padding_bottom="20px" type="legacy"][fusion_builder_row][fusion_builder_column type="1_1" layout="1_1" spacing="" center_content="no" hover_type="none" link="" min_height="" hide_on_mobile="small-visibility,medium-visibility,large-visibility" class="" id="" background_color="" background_image="" background_position="left top" undefined="" background_repeat="no-repeat" border_color="" border_style="solid" border_position="all" padding_top="" padding_right="" padding_bottom="" padding_left="" margin_top="" margin_bottom="0px" animation_type="" animation_direction="left" animation_speed="0.3" animation_offset="" last="true" border_sizes_top="0" border_sizes_bottom="0" border_sizes_left="0" border_sizes_right="0" first="true"][fusion_text columns="" column_min_width="" [...]
Aepodia, ERBC, Cynbiose, Oncodesign & PharmaLex signent un accord de partenariat pour le développement précoce, préclinique et clinique
[fusion_builder_container hundred_percent="no" equal_height_columns="no" hide_on_mobile="small-visibility,medium-visibility,large-visibility" background_position="center center" background_repeat="no-repeat" fade="no" background_parallax="none" parallax_speed="0.3" video_aspect_ratio="16:9" video_loop="yes" video_mute="yes" overlay_opacity="0.5" border_style="solid" admin_toggled="no" admin_label="Intro"][fusion_builder_row][fusion_builder_column type="1_1" layout="1_1" background_position="left top" background_color="" border_size="" border_color="" border_style="solid" border_position="all" spacing="yes" background_image="" background_repeat="no-repeat" padding="" margin_top="0px" margin_bottom="0px" class="" id="" animation_type="" animation_speed="0.3" animation_direction="left" hide_on_mobile="small-visibility,medium-visibility,large-visibility" center_content="no" last="no" min_height="" hover_type="none" link=""][fusion_text] Une belle annonce très concrète reflétant les ambitions de l'AFSSI pour la [...]
[Symposium] Nos membres associent leurs expertises de recherche translationnelle pour développer des immunothérapies
[fusion_builder_container hundred_percent="no" equal_height_columns="no" hide_on_mobile="small-visibility,medium-visibility,large-visibility" background_position="center center" background_repeat="no-repeat" fade="no" background_parallax="none" enable_mobile="no" parallax_speed="0.3" video_aspect_ratio="16:9" video_loop="yes" video_mute="yes" overlay_opacity="0.5" border_style="solid"][fusion_builder_row][fusion_builder_column type="1_1" layout="1_1" spacing="" center_content="no" hover_type="none" link="" min_height="" hide_on_mobile="small-visibility,medium-visibility,large-visibility" class="" id="" background_color="" background_image="" background_position="left top" background_repeat="no-repeat" border_size="0" border_color="" border_style="solid" border_position="all" padding="" dimension_margin="" animation_type="" animation_direction="left" animation_speed="0.3" animation_offset="" last="no"][fusion_text] Innovative & integrated solution providers in translational research to develop immunotherapies Toward Next [...]
Hu-PreciMED : Un hub pour accélérer les projets en médecine de précision Humaine
[fusion_builder_container hundred_percent="no" equal_height_columns="no" hide_on_mobile="small-visibility,medium-visibility,large-visibility" background_position="center center" background_repeat="no-repeat" fade="no" background_parallax="none" enable_mobile="no" parallax_speed="0.3" video_aspect_ratio="16:9" video_loop="yes" video_mute="yes" overlay_opacity="0.5" border_style="solid" padding_top="20px" padding_bottom="20px"][fusion_builder_row][fusion_builder_column type="1_1" layout="1_1" spacing="" center_content="no" hover_type="none" link="" min_height="" hide_on_mobile="small-visibility,medium-visibility,large-visibility" class="" id="" background_color="" background_image="" background_position="left top" background_repeat="no-repeat" border_size="0" border_color="" border_style="solid" border_position="all" padding="" dimension_margin="" animation_type="" animation_direction="left" animation_speed="0.3" animation_offset="" last="no"][fusion_text] Objectifs de Hu-PreciMED Hu-PreciMED est un hub qui articule expertises et plateformes [...]
Oncodesign lauréat des Grands Prix CFNEWS 2018 de la croissance externe, dans la catégorie Innovation
[fusion_builder_container hundred_percent="no" equal_height_columns="no" hide_on_mobile="small-visibility,medium-visibility,large-visibility" background_position="center center" background_repeat="no-repeat" fade="no" background_parallax="none" parallax_speed="0.3" video_aspect_ratio="16:9" video_loop="yes" video_mute="yes" overlay_opacity="0.5" border_style="solid"][fusion_builder_row][fusion_builder_column type="1_1" layout="1_1" background_position="left top" background_color="" border_size="" border_color="" border_style="solid" border_position="all" spacing="yes" background_image="" background_repeat="no-repeat" padding="" margin_top="0px" margin_bottom="0px" class="" id="" animation_type="" animation_speed="0.3" animation_direction="left" hide_on_mobile="small-visibility,medium-visibility,large-visibility" center_content="no" last="no" min_height="" hover_type="none" link=""][fusion_text] Dijon, France, le 1er Juin 2018 à 7h30 CEST ONCODESIGN (ALONC – FR0011766229), groupe [...]
Oncodesign signe avec ERYTECH un partenariat long-terme de Service en oncologie
Oncodesign annonce la signature d’un accord pour l’acquisition des activités de service en métabolisme, pharmacocinétique, bioanalyse et médecine translationnelle de Bertin Pharma.
Oncodesign annonce l’acquisition des activités de services pharmaceutiques et biotechs de Bertin Pharma
Oncodesign annonce la signature d’un accord pour l’acquisition des activités de service en métabolisme, pharmacocinétique, bioanalyse et médecine translationnelle de Bertin Pharma.